PMID- 33888647
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20231103
IS  - 1976-9148 (Print)
IS  - 2005-4483 (Electronic)
IS  - 1976-9148 (Linking)
VI  - 29
IP  - 4
DP  - 2021 Jul 1
TI  - Diabetic Nephropathy - a Review of Risk Factors, Progression, Mechanism, and 
      Dietary Management.
PG  - 365-372
LID - 10.4062/biomolther.2020.204 [doi]
AB  - Type 2 diabetes mellitus (T2DM) leads to many health problems like diabetic 
      nephropathy (DN). One of the key factors for chronic kidney disease and end-stage 
      renal disease (ESRD) is T2DM. Extensive work is being done to delineate the 
      pathogenesis of DN and to extend possible remedies. This review is intended to 
      understand the nature of DN risk factors, progression, effects of glycemic 
      levels, and stages of DN. We also explored the novel diagnostic and therapeutic 
      approaches for DN such as gene therapy and stem cell treatments.
FAU - Natesan, Vijayakumar
AU  - Natesan V
AD  - Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai 
      University, Annamalainagar-608002, Tamilnadu, India.
FAU - Kim, Sung-Jin
AU  - Kim SJ
AD  - Department of Pharmacology and Toxicology, Metabolic Diseases Research 
      Laboratory, School of Dentistry, Kyung Hee University, Seoul 02447, Republic of 
      Korea.
LA  - eng
PT  - Journal Article
PT  - Review
PL  - Korea (South)
TA  - Biomol Ther (Seoul)
JT  - Biomolecules & therapeutics
JID - 101472832
PMC - PMC8255138
OTO - NOTNLM
OT  - Diabetic nephropathy
OT  - Hyperglycemia
OT  - Kidney disease
OT  - Novel drugs
EDAT- 2021/04/24 06:00
MHDA- 2021/04/24 06:01
PMCR- 2021/04/23
CRDT- 2021/04/23 05:46
PHST- 2020/11/11 00:00 [received]
PHST- 2021/01/18 00:00 [revised]
PHST- 2021/03/26 00:00 [accepted]
PHST- 2021/04/24 06:00 [pubmed]
PHST- 2021/04/24 06:01 [medline]
PHST- 2021/04/23 05:46 [entrez]
PHST- 2021/04/23 00:00 [pmc-release]
AID - biomolther.2020.204 [pii]
AID - bt-29-4-365 [pii]
AID - 10.4062/biomolther.2020.204 [doi]
PST - ppublish
SO  - Biomol Ther (Seoul). 2021 Jul 1;29(4):365-372. doi: 10.4062/biomolther.2020.204.